Is a complete FULC research report available?

No complete published report is available for Fulcrum Therapeutics, Inc. (FULC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · USD

$3.76

+0.06 (+1.5%)· Recorded snapshot

Market cap	286.5M
Net income (ttm)	-85M
EPS (ttm)	-$1.21
Shares out	76.3M
Volume	1,772,479
Beta	2.63

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -85M
EPS (ttm): -$1.21
Market cap: 286.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001680581
Company name	Fulcrum Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	359616109
Earnings date	2026-11-10
Earnings time	bmo
Employees	9
Employees change	-46
Employees growth	-83.64%
Enterprise value	$-27.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-07-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US3596161097
Last 10-K release date	2026-02-24
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$286.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$3.76
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	FULC
U.S. state	Massachusetts
Website	https://www.fulcrumtx.com

Metric

Value

Amount currency

USD

CIK code

0001680581

Company name

Fulcrum Therapeutics, Inc.

Country

United States

Country code

CUSIP number

359616109

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

-46

Employees growth

-83.64%

Enterprise value

$-27.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2019-07-18

Is primary listing

Yes

Is SPAC

ISIN number

US3596161097

Last 10-K release date

2026-02-24

Last earnings date

2026-07-30

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$286.5M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$3.76

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

FULC

U.S. state

Massachusetts

Website

https://www.fulcrumtx.com

Metric	Value
Earnings yield	-32.24%
FCF / EV yield	222.43%
FCF yield	-23.3%
P/B ratio	0.91x
Price / tangible book value	0.91x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-32.24%

FCF / EV yield

222.43%

FCF yield

-23.3%

P/B ratio

0.91x

Price / tangible book value

0.91x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-9.4M
ROA	-19.59%
ROA (5Y)	-21.68%
ROCE	-27.62%
ROE	-32.38%
ROE (5Y)	-36.09%
ROIC	-20.13%

Metric

Value

Profit per employee

$-9.4M

ROA

-19.59%

ROA (5Y)

-21.68%

ROCE

-27.62%

ROE

-32.38%

ROE (5Y)

-36.09%

ROIC

-20.13%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-365,000
Depreciation and amortization	$1.2M
EBIT	$-86.6M
EBITDA	$-85.4M
EPS	$-1.21
FCF per share	$-0.87
Financing cash flow	$168.4M
Free cash flow	$-66.1M
Free cash flow minus SBC	$-79.7M
Gross profit	$-56.1M
Investing cash flow	$-96.9M
Net cash flow	$5.8M
Net income	$-85M
Operating cash flow minus SBC	$-79.3M
Operating income	$-86.6M
Stock-based compensation	$13.6M

Metric

Value

Capital expenditures

$-365,000

Depreciation and amortization

$1.2M

EBIT

$-86.6M

EBITDA

$-85.4M

EPS

$-1.21

FCF per share

$-0.87

Financing cash flow

$168.4M

Free cash flow

$-66.1M

Free cash flow minus SBC

$-79.7M

Gross profit

$-56.1M

Investing cash flow

$-96.9M

Net cash flow

$5.8M

Net income

$-85M

Operating cash flow minus SBC

$-79.3M

Operating income

$-86.6M

Stock-based compensation

$13.6M

Metric	Value
Book value per share	$4.07
Debt / equity	0.02
Long-term assets	$1.1M
Long-term liabilities	$3M
Net cash (debt)	$313.6M
Net cash / market cap	110.48%
Net cash growth	51.82%
Net debt / equity	-1.01
Piotroski F-Score	2
Shareholders' equity	$310.7M
Tangible book value	$310.7M
Tangible book value per share	$4.07
Total assets	$324M
Total cash	$318.8M
Total debt	$5.3M
Total liabilities	$13.3M
WACC	18.36%

Metric

Value

Book value per share

$4.07

Debt / equity

0.02

Long-term assets

$1.1M

Long-term liabilities

$3M

Net cash (debt)

$313.6M

Net cash / market cap

110.48%

Net cash growth

51.82%

Net debt / equity

-1.01

Piotroski F-Score

Shareholders' equity

$310.7M

Tangible book value

$310.7M

Tangible book value per share

$4.07

Total assets

$324M

Total cash

$318.8M

Total debt

$5.3M

Total liabilities

$13.3M

WACC

18.36%

Metric	Value
Current assets	$322.9M
Current liabilities	$10.3M
Current ratio	31.35
Net working capital	$-3.8M
Quick ratio	31.16
Working capital	$312.6M

Metric

Value

Current assets

$322.9M

Current liabilities

$10.3M

Current ratio

31.35

Net working capital

$-3.8M

Quick ratio

31.16

Working capital

$312.6M

Metric	Value
Buyback yield / dilution	-12.92%
Dividend yield	0%
Shareholder yield	-12.92%

Metric

Value

Buyback yield / dilution

-12.92%

Dividend yield

Shareholder yield

-12.92%

Metric	Value
150-day SMA	$4.79
1D price change	1.49%
1W price change	0.54%
1W total return	0.54%
1Y price change	-61.24%
1Y return CAGR	-61.27%
1Y total return	-61.24%
20-day SMA	$3.70
200-day SMA	$5.93
3M price change	0.27%
3M total return	0.27%
3Y price change	17.61%
3Y return CAGR	5.55%
3Y total return	17.61%
50-day SMA	$3.77
50-day SMA vs 200-day SMA	50under200
52-week high	$15.74
52-week high date	2025-12-08
52-week low	$2.83
52-week low date	2026-06-02
5Y price change	-83.9%
5Y return CAGR	-30.6%
5Y total return	-83.9%
6M price change	-51.55%
6M total return	-51.55%
All-time high	$33.10
All-time high date	2021-09-21
All-time low	$2.25
All-time low date	2023-04-12
Average true range (ATR)	$0.07
Average volume	1.4M
Beta (1Y)	1.08
Beta (2Y)	1.9
Beta (5Y)	2.63
Change from 52-week high	-76.14%
Change from 52-week low	32.69%
Change from all-time high	-88.7%
Change from all-time low	66.22%
Change from open	2.04%
Day's gap	-0.54%
Dollar volume	$6.7M
High price	$3.76
Low price	$3.68
Monthly RSI	40.81
Open price	$3.68
Position in 52-week range	100%
Premarket change	-1.35%
Premarket close	$3.70
Premarket price	$3.65
Premarket volume	333
Previous close	$3.70
Price vs 150-day SMA	-21.99%
Price vs 20-day SMA	1.16%
Price vs 200-day SMA	-36.92%
Price vs 50-day SMA	-0.72%
Relative volume	1.29
Return from IPO open	-74.34%
Return from IPO price	-76.75%
RSI	53.22
Sharpe ratio	-0.54
Sharpe ratio (3Y)	0.5
Sharpe ratio (5Y)	0.1
Sortino ratio	-0.68
Sortino ratio (3Y)	0.75
Sortino ratio (5Y)	0.2
Volume	1.8M
Weekly RSI	35.88
YTD price change	-66.93%
YTD total return	-66.93%

Metric

Value

150-day SMA

$4.79

1D price change

1.49%

1W price change

0.54%

1W total return

0.54%

1Y price change

-61.24%

1Y return CAGR

-61.27%

1Y total return

-61.24%

20-day SMA

$3.70

200-day SMA

$5.93

3M price change

0.27%

3M total return

0.27%

3Y price change

17.61%

3Y return CAGR

5.55%

3Y total return

17.61%

50-day SMA

$3.77

50-day SMA vs 200-day SMA

50under200

52-week high

$15.74

52-week high date

2025-12-08

52-week low

$2.83

52-week low date

2026-06-02

5Y price change

-83.9%

5Y return CAGR

-30.6%

5Y total return

-83.9%

6M price change

-51.55%

6M total return

-51.55%

All-time high

$33.10

All-time high date

2021-09-21

All-time low

$2.25

All-time low date

2023-04-12

Average true range (ATR)

$0.07

Average volume

1.4M

Beta (1Y)

1.08

Beta (2Y)

1.9

Beta (5Y)

2.63

Change from 52-week high

-76.14%

Change from 52-week low

32.69%

Change from all-time high

-88.7%

Change from all-time low

66.22%

Change from open

2.04%

Day's gap

-0.54%

Dollar volume

$6.7M

High price

$3.76

Low price

$3.68

Monthly RSI

40.81

Open price

$3.68

Position in 52-week range

100%

Premarket change

-1.35%

Premarket close

$3.70

Premarket price

$3.65

Premarket volume

333

Previous close

$3.70

Price vs 150-day SMA

-21.99%

Price vs 20-day SMA

1.16%

Price vs 200-day SMA

-36.92%

Price vs 50-day SMA

-0.72%

Relative volume

1.29

Return from IPO open

-74.34%

Return from IPO price

-76.75%

RSI

53.22

Sharpe ratio

-0.54

Sharpe ratio (3Y)

0.5

Sharpe ratio (5Y)

0.1

Sortino ratio

-0.68

Sortino ratio (3Y)

0.75

Sortino ratio (5Y)

0.2

Volume

1.8M

Weekly RSI

35.88

YTD price change

-66.93%

YTD total return

-66.93%

Metric	Value
Float	63.5M
Float percentage	83.21%
Shares change (QoQ)	0.06%
Shares change (YoY)	12.92%
Shares held by insiders	1.03%
Shares held by institutions	88.84%
Shares outstanding	76.3M
Short % of float	11.2%
Short % of shares	9.32%
Short ratio	4.9 days

Metric

Value

Float

63.5M

Float percentage

83.21%

Shares change (QoQ)

0.06%

Shares change (YoY)

12.92%

Shares held by insiders

1.03%

Shares held by institutions

88.84%

Shares outstanding

76.3M

Short % of float

11.2%

Short % of shares

9.32%

Short ratio

4.9 days

Fulcrum Therapeutics, Inc. (FULC)

Price

Financial snapshot

Fair-value bridge

Latest news · FULC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FULC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FULC

Frequently asked questions